Robert D. Schreiber, the Andrew M. and Jane M. Bursky Distinguished Professor at the School of Medicine, has received the 2023 Richard V. Smalley Memorial Award from the Society for Immunotherapy of Cancer.
A discovery in the lab of Amit Pathak at the McKelvey School of Engineering connects mechanobiology to nuclear condensates in healthy cells.
Siteman Cancer Center and the University of Missouri will collaborate on cancer research, with the aim to improve care throughout Missouri.
Washington University School of Medicine is joining the National Institutes of Health (NIH)’s Bridge2AI program, an estimated $130 million initiative. One project aims to develop a framework for using artificial intelligence to diagnose disease based on the sound of patients’ voices.
A new study from Washington University School of Medicine suggests a simple blood test — administered before CAR-T cell treatment is initiated — may identify which patients are predisposed to developing neurotoxic side effects after CAR-T cell therapy, which is used to treat several cancers.
An experimental combination of two drugs halts the progression of small cell lung cancer, the deadliest form of lung cancer, according to a study in mice from researchers at Washington University School of Medicine in St. Louis and colleagues.
A new study from Washington University School of Medicine has revealed the details of two key transition points in the development of pancreatic cancer. The study provides insights into treatment resistance and how immunotherapy could be harnessed to treat this aggressive tumor type.
A study in Molecular Cell led by chemist Gary Patti in Arts & Sciences shows that cancer cells don’t want to waste glucose, they just consume it too quickly. The discovery was made possible with metabolomics, which allowed Patti and his team to observe the speed at which small molecules move through cells.
Abhinav Jha and his collaborators have developed a way to measure the distribution of dangerous radiation associated with cancer treatments.
Disparities in cancer stage at diagnosis among racial and ethnic minority children and adolescents may be partially explained by health insurance coverage, finds a study from the Brown School at Washington University in St. Louis.